Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1959 7
1960 19
1961 18
1962 25
1963 46
1964 51
1965 53
1966 42
1967 44
1968 49
1969 56
1970 56
1971 63
1972 87
1973 81
1974 66
1975 66
1976 98
1977 95
1978 82
1979 103
1980 95
1981 108
1982 98
1983 110
1984 118
1985 110
1986 104
1987 82
1988 87
1989 97
1990 83
1991 81
1992 69
1993 61
1994 60
1995 82
1996 66
1997 76
1998 95
1999 78
2000 85
2001 76
2002 90
2003 130
2004 188
2005 285
2006 369
2007 308
2008 332
2009 317
2010 266
2011 284
2012 260
2013 261
2014 249
2015 234
2016 215
2017 226
2018 243
2019 252
2020 273
2021 249
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

7,608 results
Results by year
Filters applied: . Clear all
Page 1
Microemulsion containing triamcinolone acetonide for buccal administration.
Padula C, Telò I, Di Ianni A, Pescina S, Nicoli S, Santi P. Padula C, et al. Eur J Pharm Sci. 2018 Mar 30;115:233-239. doi: 10.1016/j.ejps.2018.01.031. Eur J Pharm Sci. 2018. PMID: 29414307
The amount of triamcinolone acetonide recovered in the mucosa after only 10 min. of microemulsion application was much higher than after overnight application of the commercial paste Omicilon A. This suggests that triamcinolone acetonide microemulsions …
The amount of triamcinolone acetonide recovered in the mucosa after only 10 min. of microemulsion application was much higher …
Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia.
Uwakwe LN, De Souza B, Tovar-Garza A, McMichael AJ. Uwakwe LN, et al. J Drugs Dermatol. 2020 Feb 1;19(2):128-130. doi: 10.36849/JDD.2020.4635. J Drugs Dermatol. 2020. PMID: 32129955
Dermatologists have recommended the use of intralesional triamcinolone acetonide injections (ILK) to decrease the inflammatory process, however, evidence-based proof is lacking in the literature. ...
Dermatologists have recommended the use of intralesional triamcinolone acetonide injections (ILK) to decrease the inflammatory …
[Triamcinolone acetonide without solvents].
Martínez Rubio M, Moya Moya M, Selva Otaola-Urruchi J, Martínez Lazcano T, Belmonte Martínez J. Martínez Rubio M, et al. Arch Soc Esp Oftalmol. 2012 Oct;87(10):320-3. doi: 10.1016/j.oftal.2012.04.005. Epub 2012 May 30. Arch Soc Esp Oftalmol. 2012. PMID: 23021229 Spanish.
OBJECTIVE: The purification of commercially prepared triamcinolone acetonide is important in order to avoid the potential toxic side-effects of the solvent benzyl alcohol. We present a new technique for preparation of pure triamcinolone acetonide by di …
OBJECTIVE: The purification of commercially prepared triamcinolone acetonide is important in order to avoid the potential toxi …
Triamcinolone acetonide in ocular therapeutics.
Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Jermak CM, et al. Surv Ophthalmol. 2007 Sep-Oct;52(5):503-22. doi: 10.1016/j.survophthal.2007.06.004. Surv Ophthalmol. 2007. PMID: 17719372 Review.
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. ...This comprehensive review discusses the pharmacokinetics of triamcinolone acetonide and summarizes its uses in a number of diseases, both intraocular and ext
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. ...This comprehensive review discu
Intravitreal triamcinolone acetonide.
Peyman GA, Moshfeghi DM. Peyman GA, et al. Retina. 2004 Jun;24(3):488-90. doi: 10.1097/00006982-200406000-00032. Retina. 2004. PMID: 15187684 No abstract available.
Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB, Kreissig I, Degenring R. Jonas JB, et al. Prog Retin Eye Res. 2005 Sep;24(5):587-611. doi: 10.1016/j.preteyeres.2005.01.004. Epub 2005 Mar 29. Prog Retin Eye Res. 2005. PMID: 16005407 Review.
Within the last three years, triamcinolone acetonide has increasingly been applied intravitreally as treatment option for various intraocular neovascular edematous and proliferative disorders. ...If vision increases and eventually decreases again after an intravitre …
Within the last three years, triamcinolone acetonide has increasingly been applied intravitreally as treatment option for vari …
Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
Athanasiadis Y, Tsatsos M, Sharma A, Hossain P. Athanasiadis Y, et al. J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):516-22. doi: 10.1089/jop.2012.0208. Epub 2013 Mar 13. J Ocul Pharmacol Ther. 2013. PMID: 23485045 Review.
PURPOSE: To review the existing evidence that supports the subconjunctival use of triamcinolone acetonide (TA) in the treatment of various ophthalmic diseases. METHODS: A literature search was performed for published articles about the pharmacokinetic (PK) and pharm …
PURPOSE: To review the existing evidence that supports the subconjunctival use of triamcinolone acetonide (TA) in the treatmen …
Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.
Jeal W, Faulds D. Jeal W, et al. Drugs. 1997 Feb;53(2):257-80. doi: 10.2165/00003495-199753020-00006. Drugs. 1997. PMID: 9028745 Review.
Once symptoms are under control, the dosage of aqueous triamcinolone acetonide may be reduced from 220 to 110 micrograms/day without loss of effect. ...The use of intranasal triamcinolone acetonide and oral loratadine in combination did not confer any …
Once symptoms are under control, the dosage of aqueous triamcinolone acetonide may be reduced from 220 to 110 micrograms/day w …
Intravitreal triamcinolone.
Tao Y, Jonas JB. Tao Y, et al. Ophthalmologica. 2011;225(1):1-20. doi: 10.1159/000317909. Epub 2010 Aug 7. Ophthalmologica. 2011. PMID: 20693817 Free article. Review.
BACKGROUND: to provide an update on the intravitreal use of triamcinolone acetonide. METHODS: Review of literature regarding triamcinolone-related research. RESULTS: after the introduction of bevacizumab and ranibizumab into clinical practice, intravitreal …
BACKGROUND: to provide an update on the intravitreal use of triamcinolone acetonide. METHODS: Review of literature regarding …
Resistance band training after triamcinolone acetonide injection for subacromial bursitis: A randomized clinical trial.
Zhu P, Liao B, Wang Z, Sun Z, Wei Y, Cai Y. Zhu P, et al. J Rehabil Med. 2021 Jan 5;53(1):jrm00140. doi: 10.2340/16501977-2752. J Rehabil Med. 2021. PMID: 33043381 Free article. Clinical Trial.
PATIENTS: A total of 68 patients with subacromial bursitis were randomized to a triamcinolone acetonide group or a triamcinolone acetonide plus resistance band training group. ...A lower proportion of patients in the triamcinolone acetonide
PATIENTS: A total of 68 patients with subacromial bursitis were randomized to a triamcinolone acetonide group or a triamcin
7,608 results